Correction to: Nature Immunology https://doi.org/10.1038/s41590-023-01420-5, published online 2 February 2023.
In the version of the article initially published, Anja Schütz (Protein Production & Characterization Core Facility, Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany), who produced the recombinant proteins used in this study, was inadvertently omitted from the author list. This has now been corrected in the PDF and HTML versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kemna, J., Gout, E., Daniau, L. et al. Author Correction: IFNγ binding to extracellular matrix prevents fatal systemic toxicity. Nat Immunol 25, 929 (2024). https://doi.org/10.1038/s41590-024-01835-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-024-01835-8
